课题基金 / 基金详情

Sex, sex steroids and dry eye syndromes

Sex, sex steroids and dry eye syndromes
性、性类固醇和干眼症
批准号:
8033022
负责人:
David A. Sullivan
金额:
$63.91万
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-09-30 至 2014-11-30

项目摘要

项目成果

David A. Sullivan的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):眼前泪膜在保持眼表完整性、防止微生物挑战和保持视力方面起着至关重要的作用。反过来,泪膜功能障碍可能会严重影响眼睛,导致角膜干燥、溃疡和穿孔,增加感染性疾病的发生率,并显著损害视力和失明。无数的人患有泪膜紊乱,这被称为干眼综合征,分为两种主要类型:缺水和蒸发。缺水干眼是由于泪腺分泌泪液减少所致。Sj“gren综合征(SS)就是一个例子,这是一种常见的自身免疫性疾病,主要困扰女性并破坏泪腺。蒸发性干眼通常是由眉下腺功能障碍引起的,可能是绝经期间干眼的主要原因,使用雌激素替代疗法和衰老。这项赠款申请的长期目标是检验我们的假设:(1)性类固醇在眼表和附件的生理调节以及泪膜的产生中极其重要;(2)性、性类固醇激素,特别是雄激素缺乏,是水分缺乏和蒸发性干眼综合征发病的关键病因因素。实验程序包括小鼠模型、全基因组微阵列(如基因芯片)、实时聚合酶链式反应、细胞培养、免疫分析、二维凝胶、酶分析、组织学、图像分析和激素重建实验。我们的具体目标是:(1)确定性激素和性激素影响正常泪腺和SS泪腺的机制;(2)解开性和性激素对眉板腺影响的过程;(3)探索性和性激素在控制眼表和/或附件的边界润滑和表面活性蛋白中的作用。这些研究的结果应该会极大地促进我们对性别和性类固醇影响眼前段的过程的理解。此外,这些发现可能与眼睛的健康有关,因为它们:(1)探索泪膜的调节;(2)可能导致临床治疗干眼症的特定疗法的发展。 与公共卫生相关:干眼症是导致患者去看眼科医生的主要原因之一,也是一个无法治愈的重要公共卫生问题。这种疾病困扰着3000多万美国人,其中主要是女性,并严重影响了她们的生活质量。我们建议确定干眼主要发生在女性身上的原因,并将我们的研究成果转化为新的独特治疗策略的开发,以治疗缺水和蒸发性干眼。
英文摘要
DESCRIPTION (provided by applicant): The preocular tear film plays an essential role in maintaining ocular surface integrity, protecting against microbial challenge and preserving visual acuity. Tear film dysfunction, in turn, may severely impact the eye and lead to desiccation, ulceration and perforation of the cornea, an increased incidence of infectious disease, and pronounced visual impairment and blindness. Countless people suffer from tear film disorders, which are termed dry eye syndromes and are classified into 2 major types: aqueous-deficient and evaporative. Aqueous- deficient dry eye is due to decreased tear secretion from the lacrimal gland. An example is Sj"gren's syndrome (SS), a common autoimmune disease that afflicts primarily women and destroys the lacrimal gland. Evaporative dry eye is typically caused by meibomian gland dysfunction and may be a major cause of dry eye during menopause, use of estrogen replacement therapy and aging. The long range objectives of this grant application are to test our hypotheses that: (1) sex steroids are extremely important in the physiological regulation of the ocular surface and adnexa, as well as the production of the tear film; and (2) sex, sex steroid hormones, and in particular androgen deficiency, are critical etiologic factors in the pathogenesis of both aqueous-deficient and evaporative dry eye syndromes. Experimental procedures include mouse models, whole genome microarrays (e.g. gene chips), real-time-PCR, cell cultures, immunoassays, 2D gels, enzyme assays, histology, image analysis and hormone reconstitution experiments. Our specific aims are to: (1) determine the mechanisms by which sex and sex steroids influence the normal and SS lacrimal gland; (2) unravel the processes underling the sex and sex steroid effects on the meibomian gland; and (3) explore the role of sex and sex steroids in the control of boundary lubrication and surfactant proteins at the ocular surface and/or adnexa. Results from these studies should significantly advance our understanding of the processes by which sex and sex steroids influence the anterior segment of the eye. In addition, findings may have health relatedness for the eye, because they: (1) explore the regulation of the tear film; and (2) may lead to the development of specific therapies for the clinical treatment of dry eye syndromes. PUBLIC HEALTH RELEVANCE: Dry eye syndrome is one of the leading causes of patient visits to eye care practitioners, as well as an important public health problem that has no cure. This disease afflicts over 30 million Americans, predominantly women, and significantly impacts their quality of life. We propose to determine why dry eye occurs primarily in women and to translate our research results into the development of new and unique therapeutic strategies to treat aqueous-deficient and evaporative dry eye.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NEUROENDOCRINE IMMUNE CONTROL OF LACRIMAL GLAND IMMUNITY
  • 批准号:
    2159486
  • 项目类别:
  • 资助金额:
    $30.98万
  • 财政年份:
    1985
  • 负责人:
    David A. Sullivan
  • 依托单位:
ENDOCRINE CONTROL OF THE OCULAR SECRETORY IMMUNE SYSTEM
  • 批准号:
    3260811
  • 项目类别:
  • 资助金额:
    $17.52万
  • 财政年份:
    1985
  • 负责人:
    David A. Sullivan
  • 依托单位:
ENDOCRINE CONTROL OF THE OCULAR SECRETORY IMMUNE SYSTEM
  • 批准号:
    3260812
  • 项目类别:
  • 资助金额:
    $18.88万
  • 财政年份:
    1985
  • 负责人:
    David A. Sullivan
  • 依托单位:
Gender, sex steroids and dry eye syndromes
  • 批准号:
    6620932
  • 项目类别:
  • 资助金额:
    $57.21万
  • 财政年份:
    1985
  • 负责人:
    David A. Sullivan
  • 依托单位:
海外基金